Trademark: 90750155
Status Date
Tuesday, April 2, 2024
Filing Date
Wednesday, June 2, 2021
Published for Opposition
Tuesday, April 2, 2024
9 Apparatus for transmission or reproduction of sound or images; computer tablets preloaded with software that is used to facilitate the measuring of cognitive function; desktop computers preloaded with software that is used to facilitate the measuring of cognitive function; downloadable computer software for measuring cognitive function; downloadable machine learning and artificial intelligence software for measuring cognitive function; downloadable software for tablet computers for measuring cognitive function; downloadable software for desktop computers for measuring cognitive function; parts and fittings for all the aforesaid goods
44 Medical services in the field of diagnosis and prognosis of mental impairment, neurological conditions, psychiatric conditions, dementia, effects of concussion, TBI, MS, Parkinson's, Lewy-body dementia, Alzheimer's Disease health assessment and testing for physical, psychological and cognitive purposes; medical diagnostic testing services; medical screening, monitoring and assessment services for cognitive ability; medical screening, monitoring and assessment services for mental impairment; medical screening, monitoring and assessment services for neurological conditions; medical screening, monitoring and assessment services for psychiatric conditions; medical testing for diagnostic and treatment purposes, and for monitoring of progression of any diagnosed condition and treatment efficacy; medical testing via visual imagery for diagnostic and treatment purposes; medical testing via visual imagery for monitoring of any diagnosed condition and treatment efficacy; medical analysis services for dementia diagnosis and prognosis; medical dementia screening services; rehabilitation patient care services; cognitive rehabilitation services for patients; cognitive rehabilitation services for dementia patients; medical diagnostic testing, namely, companion diagnostic testing of therapeutic products; advisory, consultancy and information for all the aforesaid services
10 Medical devices for screening and assessment of neurodegeneration; medical devices for screening and assessment of cognitive ability; medical devices for screening and assessment of mental impairment; medical devices for screening and assessment of neurological conditions; medical devices for screening and assessment of psychiatric conditions; medical devices for screening and assessment of concussion, TBI, MS, Parkinson's, Lewy-body dementia, Alzheimer's Disease; parts and fittings for all the aforesaid goods
42 Scientific and technological services, namely, research and design in the field of cognition or neurodegeneration; provision of information and data relating to medical research and development; development of computing methods, algorithms and software in relation to cognition or neurodegeneration; quantitative evaluation of performance of data-processing against bench mark references; software as a service featuring software for measuring cognitive function; advisory, consultancy and information for all the aforesaid services
Apr 2, 2024
Official Gazette Publication Confirmation E-Mailed
Apr 2, 2024
Published For Opposition
Mar 13, 2024
Notification Of Notice Of Publication E-Mailed
Feb 22, 2024
Approved For Pub - Principal Register
Feb 8, 2024
Teas/Email Correspondence Entered
Feb 8, 2024
Correspondence Received In Law Office
Feb 8, 2024
Teas Response To Office Action Received
Nov 8, 2023
Application Extension Granted/Receipt Provided
Nov 8, 2023
Application Extension To Response Period - Received
Aug 9, 2023
Notification Of Non-Final Action E-Mailed
Aug 9, 2023
Non-Final Action E-Mailed
Aug 9, 2023
Non-Final Action Written
Aug 9, 2023
Previous Allowance Count Withdrawn
Aug 1, 2023
Withdrawn From Pub - Og Review Query
Jul 14, 2023
Approved For Pub - Principal Register
Jul 14, 2023
Examiner's Amendment Entered
Jul 14, 2023
Notification Of Examiners Amendment E-Mailed
Jul 14, 2023
Examiners Amendment E-Mailed
Jul 14, 2023
Examiners Amendment -Written
Jul 14, 2023
Previous Allowance Count Withdrawn
Jul 11, 2023
Withdrawn From Pub - Og Review Query
Jun 27, 2023
Electronic Record Review Complete
Jun 23, 2023
On Hold - Electronic Record Review Required
Jun 21, 2023
Approved For Pub - Principal Register
Jun 14, 2023
Teas/Email Correspondence Entered
Jun 13, 2023
Correspondence Received In Law Office
Jun 13, 2023
Teas Response To Suspension Inquiry Received
Mar 13, 2023
Notification Of Inquiry As To Suspension E-Mailed
Mar 13, 2023
Inquiry To Suspension E-Mailed
Mar 13, 2023
Suspension Inquiry Written
Sep 12, 2022
Notification Of Letter Of Suspension E-Mailed
Sep 12, 2022
Letter Of Suspension E-Mailed
Sep 12, 2022
Suspension Letter Written
Aug 19, 2022
Teas/Email Correspondence Entered
Aug 19, 2022
Correspondence Received In Law Office
Aug 19, 2022
Teas Response To Office Action Received
Feb 22, 2022
Notification Of Non-Final Action E-Mailed
Feb 22, 2022
Non-Final Action E-Mailed
Feb 22, 2022
Non-Final Action Written
Feb 16, 2022
Assigned To Examiner
Aug 25, 2021
New Application Office Supplied Data Entered
Jun 5, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
